Acinic cell carcinoma pathophysiology

Revision as of 13:46, 5 September 2019 by Ramyar (talk | contribs)
Jump to navigation Jump to search

Acinic cell carcinoma Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Acinic cell carcinoma from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

X Ray

CT

MRI

Echocardiography or Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Surgery

Medical Therapy

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case studies

Case #1

Acinic cell carcinoma pathophysiology On the Web

Most recent articles

cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Acinic cell carcinoma pathophysiology

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Acinic cell carcinoma pathophysiology

CDC on Acinic cell carcinoma pathophysiology

Acinic cell carcinoma pathophysiology in the news

Blogs on Acinic cell carcinoma pathophysiology

Directions to Hospitals Treating Acinic cell carcinoma

Risk calculators and risk factors for Acinic cell carcinoma pathophysiology

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Ramyar Ghandriz MD[2]

Overview

Pathophysiology


Genetics

  • The development of acinic cell carcinoma is the result of multiple genetic mutations that suggest association of tumor suppression genes such as[1][2]:
    • chromosome 5q
    • chromosome 6p
    • chromosome 17p


  • Deletions of chromosome 6q
  • Loss of Y
  • Trisomy 21
  • Molucular syudies suggest that retinoblastoma pathway also can be involved with acinic cell carcinoma.[3]


Associated Conditions

Gross Pathology

  • On gross pathology, acinic cell carcinoma usually presents as a solitary, encapsulated, soft tumor of gray-whit appearance.
  • In case of recurrent lesions, the tumor is often lobulated without capsule with necrosis area.
Patien with acinic cell carcinoma[4]

Microscopic Pathology

On microscopic histopathological analysis, [feature1], [feature2], and [feature3] are characteristic findings of [disease name].

References

  1. El-Naggar, Adel K; Abdul-Karim, Fadi W; Hurr, Kenneth; Callender, David; Luna, Mario A; Batsakis, John G (1998). "Genetic Alterations in Acinic Cell Carcinoma of the Parotid Gland Determined by Microsatellite Analysis". Cancer Genetics and Cytogenetics. 102 (1): 19–24. doi:10.1016/S0165-4608(97)00273-2. ISSN 0165-4608.
  2. Sandros J, Mark J, Happonen RP, Stenman G (1988). "Specificity of 6q- markers and other recurrent deviations in human malignant salivary gland tumors". Anticancer Res. 8 (4): 637–43. PMID 3178153.
  3. Liu, T; Zhu, E; Wang, L; Okada, T; Yamaguchi, A; Okada, N (2005). "Abnormal expression of Rb pathway–related proteins in salivary gland acinic cell carcinoma". Human Pathology. 36 (9): 962–970. doi:10.1016/j.humpath.2005.06.014. ISSN 0046-8177.
  4. Sherwani, Rana; Akhtar, Kafil; Ahmad, Murad; Hasan, Abrar (2011). "Cytologic diagnosis of acinic cell carcinoma of minor salivary gland: a distinct rarely described entity". Clinics and Practice. 1 (3): 58. doi:10.4081/cp.2011.e58. ISSN 2039-7283.

Template:WH Template:WS